Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.59%61.77B | -11.82%61.41B | -21.02%20.24B | -20.47%14.33B | -1.68%12.21B | 7.78%14.62B | 33.00%69.63B | 30.00%25.62B | 42.18%18.02B | 30.90%12.42B |
| Cost of revenue | -5.54%39.7B | -14.19%42.02B | -20.93%14.55B | -28.42%10.4B | -0.77%8.14B | 13.95%8.93B | 60.76%48.98B | 53.24%18.4B | 80.10%14.53B | 51.18%8.21B |
| Gross profit | 13.86%22.07B | -6.18%19.38B | -21.23%5.69B | 12.64%3.93B | -3.45%4.07B | -0.67%5.69B | -5.63%20.66B | -6.23%7.22B | -24.24%3.49B | 3.79%4.21B |
| Operating expense | 1.64%20.66B | -0.24%20.33B | -1.89%5.26B | 0.54%5.21B | 0.90%5B | -0.41%4.85B | -2.09%20.37B | -5.01%5.36B | -0.17%5.18B | -2.03%4.96B |
| Selling and administrative expenses | 1.64%20.66B | -0.24%20.33B | -1.89%5.26B | 0.54%5.21B | 0.90%5B | -0.41%4.85B | -2.09%20.37B | -5.01%5.36B | -0.17%5.18B | -2.03%4.96B |
| -Selling and marketing expense | 1.43%18.1B | -0.67%17.85B | -2.70%4.64B | 0.09%4.6B | 0.54%4.41B | -0.47%4.2B | -1.59%17.97B | -4.16%4.76B | 0.35%4.59B | -2.02%4.39B |
| -General and administrative expense | 3.14%2.56B | 2.98%2.48B | 4.52%626.21M | 4.05%616.38M | 3.62%593.65M | -0.01%642.38M | -5.68%2.41B | -11.24%599.14M | -3.98%592.39M | -2.16%572.91M |
| Operating profit | 249.39%1.41B | -432.40%-943.93M | -76.99%428.16M | 24.37%-1.28B | -25.49%-935.45M | -2.16%845.01M | -73.75%283.97M | -9.57%1.86B | -188.95%-1.69B | 25.63%-745.46M |
| Net non-operating interest income (expenses) | 624.68%4.02M | 72.90%555K | -27.40%106K | 178.33%47K | 41.06%213K | 125.00%189K | 75.41%321K | 232.73%146K | -140.00%-60K | 264.13%151K |
| Non-operating interest income | 477.16%4.14M | -18.32%718K | -14.75%156K | 12.60%143K | -26.21%214K | -26.52%205K | -56.89%879K | -12.44%183K | -84.62%127K | -3.65%290K |
| Non-operating interest expense | -25.15%122K | -70.79%163K | 35.14%50K | -48.66%96K | -99.28%1K | -91.79%16K | -69.94%558K | -88.40%37K | -72.34%187K | -64.63%139K |
| Net investment income | 22.88%118.02M | 26.41%96.04M | 14,685.71%2.07M | 5.13%35.96M | 19.34%3.96M | 40.60%54.06M | 11.29%75.98M | -99.14%14K | 29.98%34.2M | 174.79%3.31M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 204.04%4.06M | -98.86%1.34M | -68.86%14.78M | -4.84%-21.1M | 104.62%598K | -93.13%7.06M | 117.07M | 47.46M | -20.12M | -12.94M |
| Special income (charges) | 408.82%626.45M | -202.85M | 0 | |||||||
| Less:Other special charges | -408.82%-626.45M | --202.85M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -41.10%145.45M | 17.23%246.96M | -11.16%69.33M | 118.07%96.49M | -5.66%43.2M | -10.89%37.94M | 12.36%210.65M | 82.27%78.04M | -7.61%44.25M | -16.60%45.79M |
| Income before tax | 387.84%2.31B | -216.55%-801.89M | -84.31%311.59M | 28.49%-1.17B | -25.15%-887.49M | -9.85%944.25M | -54.78%687.99M | -5.50%1.99B | -219.53%-1.64B | 6.76%-709.15M |
| Income tax | -68.43%289.03M | 293.91%915.66M | 103.33%1.17B | 30.77%-307.75M | -28.37%-292.31M | 5.20%347.19M | -53.23%232.46M | -16.34%574.7M | -132.74%-444.56M | 11.73%-227.71M |
| Net income | 217.56%2.02B | -477.04%-1.72B | -160.72%-856.94M | 27.63%-862.5M | -23.63%-595.18M | -16.78%597.06M | -55.53%455.54M | -0.24%1.41B | -271.15%-1.19B | 4.21%-481.44M |
| Net income continuous operations | 217.56%2.02B | -477.04%-1.72B | -160.72%-856.94M | 27.63%-862.5M | -23.63%-595.18M | -16.78%597.06M | -55.53%455.54M | -0.24%1.41B | -271.15%-1.19B | 4.21%-481.44M |
| Noncontrolling interests | 57.41%66.32M | 19.06%42.13M | 20.73%78.8M | 43.95%-27.74M | -62.90%-26.98M | -50.10%18.05M | -49.80%35.39M | -10.06%65.27M | -335.33%-49.49M | -29.06%-16.56M |
| Net income attributable to the company | 210.97%1.95B | -518.82%-1.76B | -169.51%-935.74M | 26.93%-834.76M | -22.23%-568.2M | -15.01%579.02M | -55.95%420.15M | 0.29%1.35B | -268.79%-1.14B | 5.08%-464.88M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 210.97%1.95B | -518.82%-1.76B | -169.51%-935.74M | 26.93%-834.76M | -22.23%-568.2M | -15.01%579.02M | -55.95%420.15M | 0.29%1.35B | -268.79%-1.14B | 5.08%-464.88M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 211.18%419.98 | -528.58%-377.75 | -171.31%-201.06 | 25.09%-179 | -24.50%-120.73 | -13.42%123.04 | -55.70%88.14 | 0.70%281.94 | -269.82%-238.94 | 5.09%-96.97 |
| Diluted earnings per share | 211.18%419.98 | -528.58%-377.75 | -171.46%-201.48 | 24.75%-179.7945 | -26.29%-122.4662 | -13.42%123.04 | -55.70%88.14 | 0.70%281.94 | -269.80%-238.94 | 5.09%-96.9727 |
| Dividend per share | 0.00%80 | 0.00%80 | 0.00%80 | 0 | 0 | 0 | 0.00%80 | 0.00%80 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |